Ribavirin oral tablet is available only as a generic drug. Ribavirin comes as an oral tablet, oral capsule, oral solution, and inhalant solution. Ribavirin oral tablet is used in combination with ...

In clinical trials, treatment with a combination of the nucleotide polymerase inhibitor sofosbuvir and the antiviral drug ribavirin was associated with high response rates among patients with ...

Ribavirin is a broad-spectrum antiviral agent predominantly used in the treatment of hepatitis C and respiratory syncytial virus (RSV) infections. The exerted antiviral effect depends substantially on ...

Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) ...

Ribavirin, the nucleoside analog 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, is a broad spectrum direct antiviral agent. This drug was discovered more than 40 years ago and is efficient both in ...

Background and Aim: Current practice guidelines recommend that individuals chronically infected with the hepatitis C virus (HCV) be treated with pegylated interferon plus ribavirin. Ribavirin, however ...

The dramatic outbreak of severe acute respiratory syndrome (SARS) has led to the use of high-dose intravenous and oral ribavirin in patients affected with this disorder. Ribavirin, a nucleoside ...

Learn everything you need to know about Ribavirin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Review the side-effects of Ribavirin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

You have full access to this article via your institution. Our studies show that ribavirin was active in both Flt3 wild type and mutant specimens (Table 1), reducing colony numbers to about 40% for ...

J Gastroenterol Hepatol. 2008;23(6):844-855. Recent studies have tested whether treatment of CHC patients with ribavirin alone increases virus mutation rates. In a randomized, placebo-controlled trial ...